The study looked at 80 patients in a double-blind, randomized, placebo-controlled, parallel group, stratified, comparative clinical study. Those taking KSM-66 had improved measures of sleep onset latency, sleep efficiency, total sleep time, and waking after sleep onset.
This is the fourth clinical study demonstrating the effects of KSM-66 on sleep quality, according to a press release on the topic.
Related: KSM-66 Ashwagandha Granted Functional Claims by Health Canada The Sleep-Stress Connection Stress, Sleep, and Health: Stay #NaturallyInformed
Kartikeya Baldwa, CEO of Ixoreal Biomed Inc, makers of KSM-66, said in the press release: “Sleep is critical to be healthy, to recover from exercise and to function optimally both physically and cognitively. Ashwagandha root has been referenced for centuries for its sleep benefits. This study is the first clinical study to evaluate the effect of Ashwagandha root extract on sleep quality in both healthy adults and insomnia patients and demonstrate significant positive effects on sleep quality in the participants. The paper is published in a prestigious journal and is a valuable contribution to the scientific literature. It substantiates the use of Ashwagandha root extract as an adaptogen that helps reduce anxiety and promote restful sleep.”
